With government budgets under pressure in mature economies, burgeoning healthcare expenditures are under scrutiny. In this light, healthcare innovation can either help by developing new cheaper treatments or make healthcare policy decisions more difficult by introducing new, better but more expensive technologies.
Health insurance, innovation, and technology adoption
Joan Costa-i-Font, Alistair McGuire, Victoria Serra-Sastre, 19 January 2013
What happens to R&D in domestic multinationals after foreign acquisition?
Roger Bandick, Holger Görg, Patrik Karpaty, 15 January 2011
The recent waves of cross-border mergers and acquisitions have raised the question as to what will happen to the domestic firms, and in particular the headquarter activities of domestic multinationals, once they are acquired by a foreign owner.
You can raise productivity through R&D, but geography matters a lot
Sergey Lychagin, John Van Reenen, Margaret E Slade, Joris Pinkse, 25 October 2010
President Obama recently proposed increasing the generosity of the US research and development (R&D) tax credit system and making it a permanent feature of the US tax code. This was justified by the idea that more R&D would lead to growth, not just worldwide but particularly in the US.
But such a bold statement raises some fundamental questions:
- A tale of two depressions: What do the new data tell us? February 2010 updateEichengreen, O’Rourke
- The ECB’s stealth bailoutSinn
- Educated in America: College graduates and high school dropoutsHeckman, LaFontaine
- Eurozone breakup would trigger the mother of all financial crisesEichengreen
- Panic-driven austerity in the Eurozone and its implicationsDe Grauwe, Ji
Adelman, 28 October 2013
Reichlin, Giugliano, 7 November 2013
Holmes, McGrattan, Prescott
Beck, De Haas, Ongena